BSE Live
Apr 07, 11:15Prev. Close
666.90
Open Price
659.95
Bid Price (Qty.)
657.50 (1)
Offer Price (Qty.)
663.80 (6)
NSE Live
Apr 07, 11:15Prev. Close
659.10
Open Price
657.75
Bid Price (Qty.)
659.60 (1)
Offer Price (Qty.)
661.55 (4)
| Balance Sheet of Albert David (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Total Share Capital | 5.71 | 5.71 | 5.71 | 5.71 | 5.71 | |
| Reserves and Surplus | 386.78 | 377.27 | 305.87 | 273.76 | 238.67 | |
| Total Reserves and Surplus | 386.78 | 377.27 | 305.87 | 273.76 | 238.67 | |
| Total Shareholders Funds | 392.48 | 382.98 | 311.57 | 279.47 | 244.38 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 6.32 | 3.28 | 0.00 | 0.40 | 0.97 | |
| Other Long Term Liabilities | 2.56 | 1.98 | 2.65 | 3.56 | 4.86 | |
| Long Term Provisions | 5.87 | 10.71 | 10.23 | 10.47 | 10.58 | |
| Total Non-Current Liabilities | 14.75 | 15.96 | 12.88 | 14.43 | 16.41 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 10.05 | 2.10 | 3.97 | 3.77 | 0.43 | |
| Trade Payables | 37.56 | 33.95 | 32.14 | 30.98 | 31.95 | |
| Other Current Liabilities | 35.97 | 43.48 | 43.25 | 50.10 | 28.23 | |
| Short Term Provisions | 20.61 | 19.52 | 19.58 | 24.10 | 20.00 | |
| Total Current Liabilities | 104.18 | 99.05 | 98.94 | 108.94 | 80.61 | |
| Total Capital And Liabilities | 511.42 | 497.99 | 423.39 | 402.84 | 341.40 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 97.71 | 81.60 | 77.56 | 83.81 | 82.49 | |
| Intangible Assets | 1.07 | 1.79 | 2.46 | 3.87 | 1.47 | |
| Capital Work-In-Progress | 1.73 | 6.67 | 2.72 | 0.81 | 0.75 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 100.70 | 90.13 | 82.74 | 88.49 | 84.71 | |
| Non-Current Investments | 17.95 | 18.84 | 25.88 | 26.56 | 23.86 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 1.92 | |
| Other Non-Current Assets | 38.71 | 17.39 | 10.37 | 33.96 | 7.23 | |
| Total Non-Current Assets | 157.37 | 126.36 | 119.98 | 149.01 | 117.72 | |
| CURRENT ASSETS | ||||||
| Current Investments | 242.21 | 254.30 | 166.78 | 156.53 | 113.82 | |
| Inventories | 63.90 | 43.61 | 50.68 | 39.18 | 35.75 | |
| Trade Receivables | 27.37 | 29.33 | 30.33 | 25.07 | 19.49 | |
| Cash And Cash Equivalents | 1.69 | 31.16 | 25.22 | 18.56 | 35.37 | |
| Short Term Loans And Advances | 4.05 | 4.07 | 9.12 | 5.12 | 13.41 | |
| OtherCurrentAssets | 14.82 | 9.15 | 21.28 | 9.37 | 5.84 | |
| Total Current Assets | 354.05 | 371.63 | 303.41 | 253.83 | 223.68 | |
| Total Assets | 511.42 | 497.99 | 423.39 | 402.84 | 341.40 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 7.50 | 5.27 | 8.23 | 2.81 | 4.07 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 25.92 | 14.34 | 30.67 | 20.69 | 11.56 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 20.26 | 25.66 | 15.61 | 17.73 | 12.71 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 17.95 | 18.84 | 25.88 | 18.70 | 18.70 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 31.59 | 41.51 | 31.04 | 20.76 | -- | |
| Current Investments Unquoted Book Value | 210.62 | 212.79 | 135.74 | 135.76 | 103.54 |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
07.04.2026
07.04.2026
06.04.2026
06.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth